All Stocks
C

CRVS

Corvus Pharmaceuticals, Inc.
Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$14.69

Market Cap

$1.23B

Beta

0.84

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)+45.36%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-2.67%
Debt / Equity0.02
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for CRVS.